As of Jan 20
| +1.36 / +1.15%|
The 6 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 161.00, with a high estimate of 208.00 and a low estimate of 135.00. The median estimate represents a +34.15% increase from the last price of 120.01.
The current consensus among 6 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.